Brandinium

Trademark search for:

ONYX PHARMACEUTICALS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-11-24 — Application filed
  • 2010-11-27 — Application filed
  • 2010-11-30 — Application filed
  • 2010-12-01 — Notice of design search code mailed
  • 2011-03-03 — Assigned to examiner
  • 2011-03-07 — Final disposition recorded
  • 2011-03-07 — Final disposition recorded
  • 2011-03-07 — Final disposition recorded
  • 2011-05-19 — Teas change of owner address received
  • 2011-05-19 — Applicant/correspondence changes (non-responsive) entered
  • 2011-09-07 — Teas/email correspondence entered
  • 2011-09-07 — Office action issued
  • 2011-09-07 — Correspondence received in law office
  • 2011-09-08 — Approved for pub - principal register
  • 2011-09-21 — Assigned to lie
  • 2011-09-22 — Law office publication review completed
  • 2011-10-25 — Published for opposition
  • 2011-10-25 — Official gazette publication confirmation e-mailed
  • 2011-12-20 — Noa e-mailed - sou required from applicant
  • 2012-06-18 — Sou teas extension received
  • 2012-06-18 — Sou extension 1 filed
  • 2012-07-11 — Case assigned to intent to use paralegal
  • 2012-07-11 — Sou extension 1 granted
  • 2012-07-12 — Notice of approval of extension request e-mailed
  • 2012-10-22 — Sou teas extension received
  • 2012-10-22 — Teas statement of use received
  • 2012-10-22 — Teas request to divide received
  • 2012-10-22 — Use amendment filed
  • 2012-10-22 — Divisional request received
  • 2012-10-24 — Divisional processing complete
  • 2012-10-24 — Statement of use processing complete
  • 2012-10-25 — Allowed principal register - sou accepted
  • 2012-10-25 — Notice of design search code mailed
  • 2012-10-30 — Law office registration review completed
  • 2012-10-31 — Notice of acceptance of statement of use e-mailed
  • 2012-12-04 — Registered-principal register
  • 2013-11-06 — Teas change of correspondence received
  • 2014-02-20 — Attorney/dom.rep.revoked and/or appointed
  • 2014-02-20 — Teas revoke/app/change addr of atty/dom rep received
  • 2016-10-10 — Teas change of owner address received
  • 2016-10-10 — Applicant/correspondence changes (non-responsive) entered
  • 2017-12-04 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2019-03-07 — Attorney/dom.rep.revoked and/or appointed
  • 2019-03-07 — Teas revoke/app/change addr of atty/dom rep received
  • 2019-07-05 — Cancelled sec. 8 (6-yr)
  • 2019-07-05 — Final status recorded

Owner Information

Onyx Pharmaceuticals, Inc.
Thousand Oaks , CA
Onyx Pharmaceuticals, Inc.
South San Francisco , CA
Onyx Pharmaceuticals, Inc.
South San Francisco , CA

Correspondent

Timothy G. Gaul Amgen Inc.
One Amgen Center Drive
Trademarks Operations
Thousand Oaks, CA 91320-1799

Filing Details

Filing Date:
2010-11-24
Status Date:
2019-07-05
Category:
Pharmaceuticals
Filing Year:
2000

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.